Gayatri Bioorganics reported zero revenue and a net loss of ₹111.18 lakh for FY2026, with negative equity of ₹11,579.31 lakh.
The Board approved audited FY2026 results and appointed M/s. Vas & Co. as Internal Auditors for FY2027.
Auditors issued an unmodified opinion but emphasized going concern reliance on promoter support and disclosed significant pending statutory disputes.
The company's financial position shows negative net worth and reliance on promoter comfort letters for continuity.